CANbridge Pharmaceuticals website screenshot

CANbridge Pharmaceuticals

CANbridge Pharmaceuticals (CANbridge Life Sciences Ltd.) is a global, China-based biopharmaceutical company founded in 2012 that focuses on the research, development, and commercialization of transformative therapies for rare diseases and rare oncology. The company in-licenses and develops differentiated drug candidates from around the world for the Chinese and global markets, with a portfolio of approved products and a gene-therapy and enzyme-replacement pipeline. Headquartered in Beijing with offices in Shanghai, Hong Kong, Taiwan, Suzhou, and Burlington, Massachusetts (USA), CANbridge is listed on the Hong Kong Stock Exchange. This profile was added to the API Evangelist network as a portfolio company of the venture firm Qiming; CANbridge publishes no public developer API, SDK, or machine-readable API surface at this time.

CANbridge Pharmaceuticals is profiled on the APIs.io network. Tagged areas include Company, Pharmaceuticals, Biotechnology, Rare Disease, and Healthcare.

CANbridge Pharmaceuticals’ developer surface includes engineering blog and 3 more developer resources.

🌐 Visit website 📡 Source on GitHub
11.2/100 minimal ▬ flat Agent 0/100 human only Full breakdown ↓
scored 2026-07-27 · rubric v0.5
0 APIs
CompanyPharmaceuticalsBiotechnologyRare DiseaseHealthcareLife SciencesGene TherapyOncology

Kin Score

Kin Score Kin Score How this is scored →
scored 2026-07-27 · rubric v0.5
Composite quality — 11.2/100 · minimal
Contract Quality 0.0 / 25
Developer Ergonomics 0.4 / 20
Commercial Clarity 2.1 / 20
Operational Transparency 0.0 / 13
Governance 0.0 / 12
Discoverability 6.8 / 10
Agent readiness — 0/100 · human only
Machine-Readable Contract 0 / 18
Agentic Access Contract 0 / 15
MCP Server 0 / 12
Machine-Readable Auth 0 / 10
Idempotency 0 / 9
Stable Error Semantics 0 / 8
Request/Response Examples 0 / 7
Rate-Limit Signaling 0 / 7
Typed Event Surface 0 / 6
Agent Skills 0 / 5
Well-Known Catalog 0 / 4
Consent & Bot Identity 0 / 3
Improve this rating by publishing the missing artifacts — every area above can be raised, and the full rubric is at apis.io/rating/. This rating is computed from github.com/api-evangelist/canbridgepharma: open an issue to ask a question, or submit a pull request to add artifacts. Want it done for you? Prioritized profiling — $2,500 →

Security Posture 1

Authentication, domain security, vulnerability disclosure, and trust-center signals.

Canbridgepharma Domain Security

TLSv1.3 · HSTS

SECURITY

Resources

Access & Security 1

Authentication, authorization, and security posture

DomainSecurity
DomainSecurity

Commercial 1

Pricing, plans, and the legal terms of use

PrivacyPolicy
PrivacyPolicy

Company 2

The organization behind the API

Website
Website
 Blog
Blog

Source (apis.yml)

apis.yml Raw ↑ 
aid: canbridgepharma
name: CANbridge Pharmaceuticals
description: CANbridge Pharmaceuticals (CANbridge Life Sciences Ltd.) is a global, China-based biopharmaceutical company founded
  in 2012 that focuses on the research, development, and commercialization of transformative therapies for rare diseases and
  rare oncology. The company in-licenses and develops differentiated drug candidates from around the world for the Chinese
  and global markets, with a portfolio of approved products and a gene-therapy and enzyme-replacement pipeline. Headquartered
  in Beijing with offices in Shanghai, Hong Kong, Taiwan, Suzhou, and Burlington, Massachusetts (USA), CANbridge is listed
  on the Hong Kong Stock Exchange. This profile was added to the API Evangelist network as a portfolio company of the venture
  firm Qiming; CANbridge publishes no public developer API, SDK, or machine-readable API surface at this time.
url: https://raw.githubusercontent.com/api-evangelist/canbridgepharma/refs/heads/main/apis.yml
accessModel:
  pricing: unknown
  onboarding: unknown
  trial: false
  try_now: false
  public: false
  label: Unknown
  confidence: low
  source: []
  generated: '2026-07-22'
  method: derived
image: https://www.canbridgepharma.com/media/images/01_CANbridge_Logo_1.jpg
x-type: company
x-source: vc-portfolio
x-backed-by:
- qiming
x-tier: stub
x-tier-reason: portfolio-lead
specificationVersion: '0.20'
created: '2026-07-17'
modified: '2026-07-18'
tags:
- Company
- Pharmaceuticals
- Biotechnology
- Rare Disease
- Healthcare
- Life Sciences
- Gene Therapy
- Oncology
apis: []
maintainers:
- FN: Kin Lane
  email: kin@apievangelist.com
- FN: APIs.json
  email: info@apis.io
common:
- type: DomainSecurity
  url: security/canbridgepharma-domain-security.yml
- type: Website
  url: https://www.canbridgepharma.com/en/
- type: PrivacyPolicy
  url: https://www.canbridgepharma.com/en/privacy-policy/
- type: Blog
  url: https://www.canbridgepharma.com/en/media-news/press-release/
x-enrichment:
  date: '2026-07-19'
  status: backfilled
  pass: local-v1
  note: backfilled from .gitignore signal + verified work evidence